Perinatal implications of cocaine exposure

Area of Science:

• Obstetrics and Gynecology
• Neonatal Health
• Substance Abuse Research

Background:

• Cocaine abuse during pregnancy poses significant risks to both mother and fetus.
• Previous pregnancies among cocaine-abusing women show high rates of adverse outcomes.
• Understanding the impact of cocaine use on obstetric outcomes is critical for intervention.

Purpose of the Study:

• To review obstetric outcomes in women with documented cocaine abuse during pregnancy.
• To identify specific complications and adverse events associated with prenatal cocaine exposure.
• To highlight the need for prevention strategies and counseling for childbearing women.

Main Methods:

• Retrospective review of obstetric outcomes for 139 women reporting cocaine abuse after 20 weeks gestation.
• Data collection on previous and current pregnancy outcomes, drug use patterns, and maternal/infant health indicators.
• Analysis of birth weight, congenital abnormalities, and neonatal complications.

Main Results:

• High rates of abortion (41.1%) and stillbirth (3.6%) in previous pregnancies.
• Significant prevalence of multiple-drug use (92%), intravenous cocaine use (44.6%), and freebasing (31.7%) in current pregnancies.
• Infants experienced significantly lower mean birth weight, low birth weight (36.2%), small size for gestational age (32.4%), neurologic problems (30.9%), and syphilis (15.4%).
• Congenital abnormalities were observed in 17.4% of infants.

Conclusions:

• Consistent poor obstetric outcomes reflect the lifestyle of cocaine abusers.
• Prenatal cocaine exposure is associated with a pattern of adverse fetal and neonatal outcomes.
• Emphasis on prevention and counseling is essential due to the lack of available cures for cocaine addiction.